CXCR4 receptor antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9353086
SERIAL NO

13878968

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are compounds that are antagonists of the CXCR4 receptor.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROXIMAGEN LLC505 HIGHWAY 169 NORTH SUITE 850 PLYMOUTH MN 55441

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Brown, Giles London, GB 9 87
Carley, Allison London, GB 8 34
Cole, Andrew Graham Cranbury, US 5 20
Higginbottom, Michael London, GB 37 122
Oliver, Kathryn London, GB 12 34
Patient, Lee London, GB 24 97
Savory, Edward Daniel London, GB 13 48
Simpson, Iain London, GB 50 163
Stewart, Alison London, GB 9 35

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 30, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00